HalioDx
HalioDx, headquartered in Marseille, France, is an immuno-oncology diagnostic company providing oncologists and drug development organizations with first-in-class Immune-based diagnostic products and services to guide cancer care and contribute to precision medicine in the era of immuno-oncology and combination therapies.
Last updated on
About HalioDx
Founded
2015Estimated Revenue
$50M-$100MEmployees
51-250Category
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
87NAICs Code
325413Location
City
MarseilleState
Provence-Alpes-Cote d'AzurCountry
FranceHalioDx
Find your buyer within HalioDx